Boston Common Asset Management LLC lessened its position in shares of Xylem Inc. (NYSE:XYL - Free Report) by 1.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 125,029 shares of the industrial products company's stock after selling 2,328 shares during the quarter. Boston Common Asset Management LLC owned about 0.05% of Xylem worth $16,174,000 as of its most recent SEC filing.
Several other large investors have also recently modified their holdings of XYL. AFG Fiduciary Services Limited Partnership acquired a new position in Xylem during the 2nd quarter valued at approximately $275,000. IFM Investors Pty Ltd increased its stake in Xylem by 11.6% during the 2nd quarter. IFM Investors Pty Ltd now owns 54,073 shares of the industrial products company's stock valued at $6,995,000 after purchasing an additional 5,617 shares in the last quarter. Dynamic Advisor Solutions LLC acquired a new position in Xylem during the 1st quarter valued at approximately $694,000. Farther Finance Advisors LLC increased its stake in Xylem by 30.4% during the 1st quarter. Farther Finance Advisors LLC now owns 1,797 shares of the industrial products company's stock valued at $215,000 after purchasing an additional 419 shares in the last quarter. Finally, BROOKFIELD Corp ON increased its stake in Xylem by 26.5% during the 1st quarter. BROOKFIELD Corp ON now owns 16,375 shares of the industrial products company's stock valued at $1,956,000 after purchasing an additional 3,430 shares in the last quarter. Institutional investors own 87.96% of the company's stock.
Xylem Stock Performance
Shares of NYSE XYL opened at $149.99 on Friday. The company's fifty day moving average price is $141.96 and its 200 day moving average price is $129.48. Xylem Inc. has a 1 year low of $100.47 and a 1 year high of $150.98. The company has a market capitalization of $36.51 billion, a PE ratio of 38.96, a price-to-earnings-growth ratio of 2.59 and a beta of 1.13. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.43 and a current ratio of 1.90.
Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The firm had revenue of $2.30 billion for the quarter, compared to the consensus estimate of $2.20 billion. During the same period in the prior year, the firm posted $1.09 earnings per share. The firm's quarterly revenue was up 6.1% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. On average, research analysts predict that Xylem Inc. will post 4.65 earnings per share for the current year.
Xylem Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend was Thursday, August 28th. Xylem's dividend payout ratio (DPR) is presently 41.56%.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on XYL shares. UBS Group upped their price target on shares of Xylem from $164.00 to $168.00 and gave the company a "buy" rating in a research note on Tuesday, August 5th. Citigroup reiterated a "buy" rating and issued a $152.00 price objective (up previously from $137.00) on shares of Xylem in a research note on Monday, July 14th. Weiss Ratings reiterated a "buy (b)" rating on shares of Xylem in a research note on Saturday, September 27th. TD Cowen increased their price objective on shares of Xylem from $125.00 to $130.00 and gave the stock a "hold" rating in a research note on Tuesday, August 26th. Finally, Stifel Nicolaus increased their price objective on shares of Xylem from $162.00 to $175.00 and gave the stock a "buy" rating in a research note on Friday, August 1st. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $152.33.
Read Our Latest Stock Analysis on Xylem
Insider Transactions at Xylem
In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction on Friday, September 5th. The shares were sold at an average price of $139.96, for a total transaction of $139,960.00. Following the transaction, the chief accounting officer directly owned 2,957 shares of the company's stock, valued at $413,861.72. This trade represents a 25.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.27% of the stock is currently owned by insiders.
Xylem Company Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Further Reading
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.